𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pamidronate and osteoporosis prevention in liver transplant recipients

✍ Scribed by Pietra Pennisi; Andrea Trombetti; Emiliano Giostra; Gilles Mentha; René Rizzoli; Carmelo E. Fiore

Book ID
106007178
Publisher
Springer
Year
2006
Tongue
English
Weight
134 KB
Volume
27
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adherence in liver transplant recipients
Adherence in liver transplant recipients
✍ Patrizia Burra; Giacomo Germani; Francesca Gnoato; Silvia Lazzaro; Francesco Pao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to i

Smoking behavior in liver transplant rec
Smoking behavior in liver transplant recipients
✍ Frans van der Heide; Gerard Dijkstra; Robert J. Porte; Jan H. Kleibeuker; Elizab 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Long-term morbidity and survival after orthotopic liver transplantation (OLT) are to a large degree determined by cardiovascular disease and cancer. Tobacco use is a well-known risk factor for both. The aim of this study was to examine smoking behavior before and after OLT and to define groups at ri

Antifungal prophylaxis in liver transpla
Antifungal prophylaxis in liver transplant recipients
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Hepatitis B in liver transplant recipien
Hepatitis B in liver transplant recipients
✍ Robert G. Gish; Timothy McCashland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire